| OHR | occupational health research; Office of Health Research |
|---|---|
| BSID | Boyley Scales of Infant Development; Boyley 유아 발달 척도 |
| CHARGE Associations | Coloboma Heart disease Atresia choanae Reta... |
| KIDS | Kansas Infant Development Screen |
| AHSDF | area health service development fund |
| chemotherapy drug sensitivity test | <investigation> A test to assess a cancerous tissue's response and vulnerability to chemotherapy drugs. This test can help predict a patients response to treatment and suggest which drugs may be useful. (16 Dec 1997) |
|---|---|
| metabolic detoxication, drug | Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. (12 Dec 1998) |
| multiple drug resistant tuberculosis | A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance. (09 Oct 1997) |
| crude drug | Any raw or unrefined medicinal compound in its natural form, especiallyone taken from a plant. (09 Oct 1997) |
| prescription drug | A drug requiring a prescription, a physician's order. By comparison with an over-the-counter drug. (12 Dec 1998) |
| prescriptions, drug | Directions written for the preparation and adminstration of a drug. (12 Dec 1998) |
| prescriptions, non-drug | Written directions for the preparation, administration, or application of a non-drug remedy. This includes prescriptions for corrective lenses, self-help and orthopedic devices, and physical therapy and rehabilitation measures. (12 Dec 1998) |
| hepatitis, chronic, drug-induced | An inflammatory disease of the liver, lasting six months or more, and caused by an adverse drug effect. The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite. The clinical and histological changes can mimic viral or autoimmune hepatitis. (12 Dec 1998) |
| scheduled drug | A drug assigned to any of the five schedules in the Controlled Substances Act (1970). See: controlled substance. (05 Mar 2000) |
| psychedelic drug | <pharmacology> A class of medications (for example LSD, marijuana, peyote, heroin, cocaine) that result in a distorted perception of reality. Often accompanied by hallucinations. (27 Sep 1997) |
| psychodysleptic drug | <pharmacology> A class of medications (for example LSD, marijuana, peyote, heroin, cocaine) that result in a distorted perception of reality. Often accompanied by hallucinations. (27 Sep 1997) |
| psycholytic drug | <pharmacology> A class of medications (for example LSD, marijuana, peyote, heroin, cocaine) that result in a distorted perception of reality. Often accompanied by hallucinations. (27 Sep 1997) |
| psychotomimetic drug | <pharmacology> A class of medications (for example LSD, marijuana, peyote, heroin, cocaine) that result in a distorted perception of reality. Often accompanied by hallucinations. (27 Sep 1997) |
| psychotropic drug | Any drug that affects the mind. (05 Mar 2000) |
| nephrotoxic drug | A group of medication known to cause renal toxicity in some cases as a side effect. Examples include: aminoglycosides, cisplatin, cyclosporine, foscarnet, pentamidine, ifosfamide, vancomycin, neomycin, nitrous oxide, isoflurane, kanamycin and cyclophosphamide. (27 Sep 1997) |